13F-HR filed by MPM BIOIMPACT LLC
MPM BIOIMPACT LLC filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-13, with 32 holding rows worth $427,428,816.
- Accession
- 0000950123-24-001863
- Filer
- CIK 1687078
- Filed
- 2024-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 32 entries on the cover page, a total value of $427,428,816 stated on the cover page (in dollars after the unit check, H1), rows summing to $427,428,816 with VALUE read as dollars as filed, 13F file number 028-20107. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 7,648,268 | $77,935,851 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 3,289,470 | $26,743,391 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 1,857,136 | $26,055,618 | dollars as filed | |
| GERON CORP | 374163103 | COM | 10,715,620 | $22,609,958 | dollars as filed | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 1,745,943 | $19,118,076 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 1,264,759 | $18,832,262 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 294,576 | $17,789,445 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 478,234 | $17,015,566 | dollars as filed | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 53,279 | $16,863,336 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 528,150 | $16,367,369 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 611,181 | $14,436,095 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 1,639,849 | $11,970,898 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 382,598 | $11,665,413 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 715,883 | $10,158,380 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 549,078 | $9,855,950 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 40,910 | $9,465,756 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 230,696 | $9,403,169 | dollars as filed | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 664,986 | $9,389,602 | dollars as filed | |
| MORPHIC HLDG INC | 61775R105 | COM | 323,742 | $9,349,669 | dollars as filed | |
| WEREWOLF THERAPEUTICS INC | 95075A107 | CMN | 2,388,011 | $9,217,722 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 832,017 | $9,160,507 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 3,847,232 | $9,040,995 | dollars as filed | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 638,163 | $8,895,992 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 273,408 | $7,841,341 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 93,387 | $7,432,671 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 325,284 | $6,053,535 | dollars as filed | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 5,095,912 | $4,041,058 | dollars as filed | |
| HARPOON THERAPEUTICS INC | 41358P205 | COM | 319,670 | $3,634,648 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 50,000 | $2,888,000 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 100,000 | $2,178,000 | dollars as filed | |
| INOZYME PHARMA INC | 45790W108 | COM | 323,813 | $1,379,443 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 70,000 | $639,100 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-24-001863 | this filing | 2024-02-13 | acceptance time not in the bulk data set |